Lectin-Like Interactions in Virus-Cell Recognition: Human Immunodeficiency Virus and C-Type Lectin Interactions

Microbial Glycobiology

Volumn , Issue , 2010, Pages 567-584

  Steffen, Imke ^a   Tsegaye, Theodros S ^a   Pöhlmann, Stefan ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882866376     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-374546-0.00028-6     Document Type: Chapter

References (117)

1. Alvarez C.P., Lasala F., Carrillo J., Muniz O., Corbi A.L., Delgado R. C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans. J. Virol. 2002, 76:6841-6844.
2. Arrighi J.F., Pion M., Garcia E., et al. DC-SIGN-mediated infectious synapse formation enhances X4 HIV-1 transmission from dendritic cells to T cells. J. Exp. Med. 2004, 200:1279-1288.
3. Arrighi J.F., Pion M., Wiznerowicz M., et al. Lentivirus-mediated RNA interference of DC-SIGN expression inhibits human immunodeficiency virus transmission from dendritic cells to T cells. J. Virol. 2004, 78:10848-10855.
4. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature 1998, 392:245-252.
5. Baribaud F., Pöhlmann S., Sparwasser T., et al. Functional and antigenic characterization of human, rhesus macaque, pigtailed macaque, and murine DC-SIGN. J. Virol. 2001, 75:10281-10289.
6. Baribaud F., Pöhlmann S., Leslie G., Mortari F., Doms R.W. Quantitative expression and virus transmission analysis of DC-SIGN on monocyte-derived dendritic cells. J. Virol. 2002, 76:9135-9142.
7. Bashirova A.A., Geijtenbeek T.B., van Duijnhoven G.C., et al. A dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin (DC-SIGN)-related protein is highly expressed on human liver sinusoidal endothelial cells and promotes HIV-1 infection. J. Exp. Med. 2001, 193:671-678.
8. Bernstein H.B., Tucker S.P., Hunter E., Schutzbach J.S., Compans R.W. Human immunodeficiency virus type 1 envelope glycoprotein is modified by O-linked oligosaccharides. J. Virol. 1994, 68:463-468.
9. Boggiano C., Manel N., Littman D.R. Dendritic cell-mediated trans-enhancement of human immunodeficiency virus type 1 infectivity is independent of DC-SIGN. J. Virol. 2007, 81:2519-2523.
10. Boukour S., Masse J.M., Benit L., Dubart-Kupperschmitt A., Cramer E.M. Lentivirus degradation and DC-SIGN expression by human platelets and megakaryocytes. J. Thromb. Haemost. 2006, 4:426-435.
11. Burleigh L., Lozach P.Y., Schiffer C., et al. Infection of dendritic cells (DCs), not DC-SIGN-mediated internalization of human immunodeficiency virus, is required for long-term transfer of virus to T cells. J. Virol. 2006, 80:2949-2957.
12. Cameron P.U., Freudenthal P.S., Barker J.M., Gezelter S., Inaba K., Steinman R.M. Dendritic cells exposed to human immunodeficiency virus type-1 transmit a vigorous cytopathic infection to CD4+ T cells. Science 1992, 257:383-387.
13. Cavrois M., Neidleman J., Kreisberg J.F., Greene W.C. In vitro derived dendritic cells trans-infect CD4 T cells primarily with surface-bound HIV-1 virions. PLoS Pathog. 2007, 3:e4.
14. Ceccaldi P.E., Delebecque F., Prevost M.C., et al. DC-SIGN facilitates fusion of dendritic cells with human T-cell leukemia virus type 1 infected cells. J. Virol. 2006, 80:4771-4780.
15. Chaipan C., Soilleux E.J., Simpson P., et al. DC-SIGN and CLEC-2 mediate human immunodeficiency virus type 1 capture by platelets. J. Virol. 2006, 80:8951-8960.
16. Cohen M.S., Hellmann N., Levy J.A., DeCock K., Lange J. The spread, treatment, and prevention of HIV-1: evolution of a global pandemic. J. Clin. Invest. 2008, 118:1244-1254.
17. Curtis B.M., Scharnowske S., Watson A.J. Sequence and expression of a membrane-associated C-type lectin that exhibits CD4-independent binding of human immunodeficiency virus envelope glycoprotein gp120. Proc. Natl. Acad. Sci. USA 1992, 89:8356-8360.
18. Dakappagari N., Maruyama T., Renshaw M., et al. Internalizing antibodies to the C-type lectins, L-SIGN and DC-SIGN, inhibit viral glycoprotein binding and deliver antigen to human dendritic cells for the induction of T cell responses. J. Immunol. 2006, 176:426-440.
19. Davis C.W., Nguyen H.Y., Hanna S.L., Sanchez M.D., Doms R.W., Pierson T.C. West Nile virus discriminates between DC-SIGN and DC-SIGNR for cellular attachment and infection. J. Virol. 2006, 80:1290-1301.
20. Davis C.W., Mattei L.M., Nguyen H.Y., Ansarah-Sobrinho C., Doms R.W., Pierson T.C. The location of asparagine-linked glycans on West Nile virions controls their interactions with CD209 (dendritic cell-specific ICAM-3 grabbing nonintegrin). J. Biol. Chem. 2006, 281:37183-37194.
21. de Jong M.A., de Witte L., Bolmstedt A., van Kooyk Y., Geijtenbeek T.B. Dendritic cells mediate herpes simplex virus infection and transmission through the C-type lectin DC-SIGN. J. Gen. Virol. 2008, 89:2398-2409.
22. De Milito A. B lymphocyte dysfunctions in HIV infection. Curr. HIV Res. 2004, 2:11-21.
23. de Witte L., Abt M., Schneider-Schaulies S., van Kooyk Y., Geijtenbeek T.B. Measles virus targets DC-SIGN to enhance dendritic cell infection. J. Virol. 2006, 80:3477-3486.
24. de Witte L., Nabatov A., Pion M., et al. Langerin is a natural barrier to HIV-1 transmission by Langerhans cells. Nat. Med. 2007, 13:367-371.
25. Engering A., Geijtenbeek T.B., Van Vliet S.J., et al. The dendritic cell-specific adhesion receptor DC-SIGN internalizes antigen for presentation to T cells. J. Immunol. 2002, 168:2118-2126.
26. Este J.A., Telenti A. HIV entry inhibitors. Lancet 2007, 370:81-88.
27. Feinberg H., Mitchell D.A., Drickamer K., Weis W.I. Structural basis for selective recognition of oligosaccharides by DC-SIGN and DC-SIGNR. Science 2001, 294:2163-2166.
28. Feinberg H., Guo Y., Mitchell D.A., Drickamer K., Weis W.I. Extended neck regions stabilize tetramers of the receptors DC-SIGN and DC-SIGNR. J. Biol. Chem. 2005, 280:1327-1335.
29. Garcia E., Pion M., Pelchen-Matthews A., et al. HIV-1 trafficking to the dendritic cell-T-cell infectious synapse uses a pathway of tetraspanin sorting to the immunological synapse. Traffic 2005, 6:488-501.
30. Gardner J.P., Durso R.J., Arrigale R.R., et al. L-SIGN (CD 209L) is a liver-specific capture receptor for hepatitis C virus. Proc. Natl. Acad. Sci. USA 2003, 100:4498-4503.
31. Geijtenbeek T.B., Torensma R., Van Vliet S.J., et al. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 2000, 100:575-585.
32. Geijtenbeek T.B., Kwon D.S., Torensma R., et al. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 2000, 100:587-597.
33. Geijtenbeek T.B., van Duijnhoven G.C., Van Vliet S.J., et al. Identification of different binding sites in the dendritic cell-specific receptor DC-SIGN for intercellular adhesion molecule 3 and HIV-1. J. Biol. Chem. 2002, 277:11314-11320.
34. Gramberg T., Zhu T., Chaipan C., et al. Impact of polymorphisms in the DC-SIGNR neck domain on the interaction with pathogens. Virology 2006, 347:354-363.
35. Gramberg T., Soilleux E., Fisch T., et al. Interactions of LSECtin and DC-SIGN/DC-SIGNR with viral ligands: differential pH dependence, internalization and virion binding. Virology 2008, 373:189-201.
36. Granelli-Piperno A., Pritsker A., Pack M., et al. Dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin/CD209 is abundant on macrophages in the normal human lymph node and is not required for dendritic cell stimulation of the mixed leukocyte reaction. J. Immunol. 2005, 175:4265-4273.
37. Gummuluru S., Rogel M., Stamatatos L., Emerman M. Binding of human immunodeficiency virus type 1 to immature dendritic cells can occur independently of DC-SIGN and mannose binding C-type lectin receptors via a cholesterol-dependent pathway. J. Virol. 2003, 77:12865-12874.
38. Guo Y., Feinberg H., Conroy E., et al. Structural basis for distinct ligand-binding and targeting properties of the receptors DC-SIGN and DC-SIGNR. Nat. Struct. Mol. Biol. 2004, 11:591-598.
39. Halary F., Amara A., Lortat-Jacob H., et al. Human cytomegalovirus binding to DC-SIGN is required for dendritic cell infection and target cell trans-infection. Immunity 2002, 17:653-664.
40. He B., Qiao X., Klasse P.J., et al. HIV-1 envelope triggers polyclonal Ig class switch recombination through a CD40-independent mechanism involving BAFF and C-type lectin receptors. J. Immunol. 2006, 176:3931-3941.
41. Hodges A., Sharrocks K., Edelmann M., et al. Activation of the lectin DC-SIGN induces an immature dendritic cell phenotype triggering Rho-GTPase activity required for HIV-1 replication. Nat. Immunol. 2007, 8:569-577.
42. Hofmann H., Simmons G., Rennekamp A.J., et al. Highly conserved regions within the spike proteins of human coronaviruses 229E and NL63 determine recognition of their respective cellular receptors. J. Virol. 2006, 80:8639-8652.
43. Hu J., Gardner M.B., Miller C.J. Simian immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells. J. Virol. 2000, 74:6087-6095.
44. Jeffers S.A., Tusell S.M., Gillim-Ross L., et al. CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus. Proc. Natl. Acad. Sci. USA 2004, 101:15748-15753.
45. Ji X., Chen Y., Faro J., Gewurz H., Bremer J., Spear G.T. Interaction of human immunodeficiency virus (HIV) glycans with lectins of the human immune system. Curr. Protein Pept. Sci. 2006, 7:317-324.
46. Kawamura T., Kurtz S.E., Blauvelt A., Shimada S. The role of Langerhans cells in the sexual transmission of HIV. J. Dermatol. Sci. 2005, 40:147-155.
47. Kawamura T., Koyanagi Y., Nakamura Y., et al. Significant virus replication in Langerhans cells following application of HIV to abraded skin: relevance to occupational transmission of HIV. J. Immunol. 2008, 180:3297-3304.
48. Khoo U.S., Chan K.Y., Chan V.S., Lin C.L. DC-SIGN and L-SIGN: the SIGNs for infection. J. Mol. Med. 2008, 86:861-874.
49. Klimstra W.B., Nangle E.M., Smith M.S., Yurochko A.D., Ryman K.D. DC-SIGN and L-SIGN can act as attachment receptors for alphaviruses and distinguish between mosquito cell- and mammalian cell-derived viruses. J. Virol. 2003, 77:12022-12032.
50. Krutzik S.R., Tan B., Li H., et al. TLR activation triggers the rapid differentiation of monocytes into macrophages and dendritic cells. Nat. Med. 2005, 11:653-660.
51. Kwon D.S., Gregorio G., Bitton N., Hendrickson W.A., Littman D.R. DC-SIGN-mediated internalization of HIV is required for trans-enhancement of T cell infection. Immunity 2002, 16:135-144.
52. Lai W.K., Sun P.J., Zhang J., et al. Expression of DC-SIGN and DC-SIGNR on human sinusoidal endothelium: a role for capturing hepatitis C virus particles. Am. J. Pathol. 2006, 169:200-208.
53. Lee T.H., Stromberg R.R., Heitman J.W., Sawyer L., Hanson C.V., Busch M.P. Distribution of HIV type 1 (HIV-1) in blood components: detection and significance of high levels of HIV-1 associated with platelets. Transfusion 1998, 38:580-588.
54. Lichterfeld M., Nischalke H.D., van Lunzen J., et al. The tandem-repeat polymorphism of the DC-SIGNR gene does not affect the susceptibility to HIV infection and the progression to AIDS. Clin. Immunol. 2003, 107:55-59.
55. Lin G., Simmons G., Pöhlmann S., et al. Differential N-linked glycosylation of human immunodeficiency virus and Ebola virus envelope glycoproteins modulates interactions with DC-SIGN and DC-SIGNR. J. Virol. 2003, 77:1337-1346.
56. Liu H., Hwangbo Y., Holte S., et al. Analysis of genetic polymorphisms in CCR5, CCR2, stromal cell-derived factor-1, RANTES, and dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin in seronegative individuals repeatedly exposed to HIV-1. J. Infect. Dis. 2004, 190:1055-1058.
57. Liu H., Hladik F., Andrus T., et al. Most DC-SIGNR transcripts at mucosal HIV transmission sites are alternatively spliced isoforms. Eur. J. Hum. Genet. 2005, 13:707-715.
58. Liu H., Carrington M., Wang C., et al. Repeat-region polymorphisms in the gene for the dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin-related molecule: effects on HIV-1 susceptibility. J. Infect. Dis. 2006, 193:698-702.
59. Liu W., Tang L., Zhang G., et al. Characterization of a novel C-type lectin-like gene, LSECtin: demonstration of carbohydrate binding and expression in sinusoidal endothelial cells of liver and lymph node. J. Biol. Chem. 2004, 279:18748-18758.
60. Liu Y.J. Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. Cell 2001, 106:259-262.
61. Lozach P.Y., Lortat-Jacob H., de Lacroix d.L., et al. DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2. J. Biol. Chem. 2003, 278:20358-20366.
62. Martin M.P., Lederman M.M., Hutcheson H.B., et al. Association of DC-SIGN promoter polymorphism with increased risk for parenteral, but not mucosal, acquisition of human immunodeficiency virus type 1 infection. J. Virol. 2004, 78:14053-14056.
63. Marzi A., Gramberg T., Simmons G., et al. DC-SIGN and DC-SIGNR interact with the glycoprotein of Marburg virus and the S protein of severe acute respiratory syndrome coronavirus. J. Virol. 2004, 78:12090-12095.
64. McDonald D., Wu L., Bohks S.M., KewalRamani V.N., Unutmaz D., Hope T.J. Recruitment of HIV and its receptors to dendritic cell-T cell junctions. Science 2003, 300:1295-1297.
65. Mitchell D.A., Fadden A.J., Drickamer K. A novel mechanism of carbohydrate recognition by the C-type lectins DC-SIGN and DC-SIGNR. Subunit organization and binding to multivalent ligands. J. Biol. Chem. 2001, 276:28939-28945.
66. Moris A., Nobile C., Buseyne F., Porrot F., Abastado J.P., Schwartz O. DC-SIGN promotes exogenous MHC-I-restricted HIV-1 antigen presentation. Blood 2004, 103:2648-2654.
67. Moris A., Pajot A., Blanchet F., Guivel-Benhassine F., Salcedo M., Schwartz O. Dendritic cells and HIV-specific CD4+ T cells: HIV antigen presentation, T-cell activation, and viral transfer. Blood 2006, 108:1643-1651.
68. Mummidi S., Catano G., Lam L., et al. Extensive repertoire of membrane-bound and soluble dendritic cell-specific ICAM-3-grabbing nonintegrin 1 (DC-SIGN1) and DC-SIGN2 isoforms. Inter-individual variation in expression of DC-SIGN transcripts. J. Biol. Chem. 2001, 276:33196-33212.
69. Münch J., Rucker E., Standker L., et al. Semen-derived amyloid fibrils drastically enhance HIV infection. Cell 2007, 131:1059-1071.
70. Navarro-Sanchez E., Altmeyer R., Amara A., et al. Dendritic-cell-specific ICAM3-grabbing non-integrin is essential for the productive infection of human dendritic cells by mosquito-cell-derived dengue viruses. EMBO Rep. 2003, 4:723-728.
71. Nobile C., Petit C., Moris A., et al. Covert human immunodeficiency virus replication in dendritic cells and in DC-SIGN-expressing cells promotes long-term transmission to lymphocytes. J. Virol. 2005, 79:5386-5399.
72. Piguet V., Steinman R.M. The interaction of HIV with dendritic cells: outcomes and pathways. Trends Immunol. 2007, 28:503-510.
73. Pöhlmann S., Reeves J.D. Cellular entry of HIV: evaluation of therapeutic targets. Curr. Pharm. Des. 2006, 12:1963-1973.
74. Pöhlmann S., Tremblay M.J. Attachment of human immunodeficiency virus to cells and its inhibition. Milestones in Drug Therapy: Entry Inhibitors in HIV Therapy 2007, 31-48. Birkhäuser, Basel. J.D. Reeves, C.A. Derdeyn (Eds.).
75. Pöhlmann S., Soilleux E.J., Baribaud F., et al. DC-SIGNR, a DC-SIGN homologue expressed in endothelial cells, binds to human and simian immunodeficiency viruses and activates infection in trans. Proc. Natl. Acad. Sci. USA 2001, 98:2670-2675.
76. Pöhlmann S., Baribaud F., Lee B., et al. DC-SIGN interactions with human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus. J. Virol. 2001, 75:4664-4672.
77. Pöhlmann S., Leslie G.J., Edwards T.G., et al. DC-SIGN interactions with human immunodeficiency virus: virus binding and transfer are dissociable functions. J. Virol. 2001, 75:10523-10526.
78. Pöhlmann S., Zhang J., Baribaud F., et al. Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR. J. Virol. 2003, 77:4070-4080.
79. Pope M., Betjes M.G., Romani N., et al. Conjugates of dendritic cells and memory T lymphocytes from skin facilitate productive infection with HIV-1. Cell 1994, 78:389-398.
80. Rappocciolo G., Jenkins F.J., Hensler H.R., et al. DC-SIGN is a receptor for human herpesvirus 8 on dendritic cells and macrophages. J. Immunol. 2006, 176:1741-1749.
81. Rappocciolo G., Piazza P., Fuller C.L., et al. DC-SIGN on B lymphocytes is required for transmission of HIV-1 to T lymphocytes. PLoS Pathog. 2006, 2:e70.
82. Rathore A., Chatterjee A., Sivarama P., Yamamoto N., Dhole T.N. Role of homozygous DC-SIGNR 5/5 tandem repeat polymorphism in HIV-1 exposed seronegative North Indian individuals. J. Clin. Immunol. 2008, 28:50-57.
83. Rathore A., Chatterjee A., Sood V., et al. Risk for HIV-1 infection is not associated with repeat-region polymorphism in the DC-SIGN neck domain and novel genetic DC-SIGN variants among North Indians. Clin. Chim. Acta 2008, 391:1-5.
84. Reeves J.D., Barr S.D., Pöhlmann S. Evaluation of current strategies to inhibit HIV entry, integration and maturation. New Concepts of Antiviral Therapy 2006, 213-254. Springer, Dordrecht. E. Bogner, A. Holzenburg (Eds.).
85. Rieg G., Yeaman M., Lail A.E., Donfield S.M., Gomperts E.D., Daar E.S. Platelet count is associated with plasma HIV type 1 RNA and disease progression. AIDS Res. Hum. Retroviruses 2007, 23:1257-1261.
86. Sakuntabhai A., Turbpaiboon C., Casademont I., et al. A variant in the CD209 promoter is associated with severity of dengue disease. Nat. Genet. 2005, 37:507-513.
87. Scanlan C.N., Offer J., Zitzmann N., Dwek R.A. Exploiting the defensive sugars of HIV-1 for drug and vaccine design. Nature 2007, 446:1038-1045.
88. Scaradavou A. HIV-related thrombocytopenia. Blood Rev. 2002, 16:73-76.
89. Serrano-Gomez D., Sierra-Filardi E., Martinez-Nunez R.T., et al. Structural requirements for multimerization of the pathogen receptor dendritic cell-specific ICAM3-grabbing non-integrin (CD209) on the cell surface. J. Biol. Chem. 2008, 283:3889-3903.
90. Simmons G., Reeves J.D., Grogan C.C., et al. DC-SIGN and DC-SIGNR bind Ebola glycoproteins and enhance infection of macrophages and endothelial cells. Virology 2003, 305:115-123.
91. Snyder G.A., Ford J., Torabi-Parizi P., et al. Characteri-zation of DC-SIGN/R interaction with human immunodeficiency virus type 1 gp120 and ICAM molecules favors the receptor's role as an antigen-capturing rather than an adhesion receptor. J. Virol. 2005, 79:4589-4598.
92. Soilleux E.J., Coleman N. Langerhans cells and the cells of Langerhans cell histiocytosis do not express DC-SIGN. Blood 2001, 98:1987-1988.
93. Soilleux E.J., Morris L.S., Lee B., et al. Placental expression of DC-SIGN may mediate intrauterine vertical transmission of HIV. J. Pathol. 2001, 195:586-592.
94. Soilleux E.J., Morris L.S., Leslie G., et al. Constitutive and induced expression of DC-SIGN on dendritic cell and macrophage subpopulations in situ and in vitro. J. Leukoc. Biol. 2002, 71:445-457.
95. Spira A.I., Marx P.A., Patterson B.K., et al. Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques. J. Exp. Med. 1996, 183:215-225.
96. Steffan A.M., Lafon M.E., Gendrault J.L., et al. Primary cultures of endothelial cells from the human liver sinusoid are permissive for human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 1992, 89:1582-1586.
97. Tassaneetrithep B., Burgess T.H., Granelli-Piperno A., et al. DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. J. Exp. Med. 2003, 197:823-829.
98. Trumpfheller C., Park C.G., Finke J., Steinman R.M., Granelli-Piperno A. Cell type-dependent retention and transmission of HIV-1 by DC-SIGN. Int. Immunol. 2003, 15:289-298.
99. Turville S.G., Cameron P.U., Handley A., et al. Diversity of receptors binding HIV on dendritic cell subsets. Nat. Immunol. 2002, 3:975-983.
100. Turville S.G., Santos J.J., Frank I., et al. Immuno-deficiency virus uptake, turnover, and 2-phase transfer in human dendritic cells. Blood 2004, 103:2170-2179.
101. van Kooyk Y., Geijtenbeek T.B. DC-SIGN: escape mechanism for pathogens. Nat. Rev. Immunol. 2003, 3:697-709.
102. van Kooyk Y., Rabinovich G.A. Protein-glycan interactions in the control of innate and adaptive immune responses. Nat. Immunol. 2008, 9:593-601.
103. van Lent P.L., Figdor C.G., Barrera P., et al. Expression of the dendritic cell-associated C-type lectin DC-SIGN by inflammatory matrix metalloproteinase-producing macrophages in rheumatoid arthritis synovium and interaction with intercellular adhesion molecule 3-positive T cells. Arthritis Rheum. 2003, 48:360-369.
104. van Montfort T., Nabatov A.A., Geijtenbeek T.B., Pollakis G., Paxton W.A. Efficient capture of antibody neutralized HIV-1 by cells expressing DC-SIGN and transfer to CD4+ T lymphocytes. J. Immunol. 2007, 178:3177-3185.
105. Veazey R.S., Lackner A.A. Getting to the guts of HIV pathogenesis. J. Exp. Med. 2004, 200:697-700.
106. Vigerust D.J., Shepherd V.L. Virus glycosylation: role in virulence and immune interactions. Trends Microbiol. 2007, 15:211-218.
107. Wang J.H., Janas A.M., Olson W.J., KewalRamani V.N., Wu L. CD4 coexpression regulates DC-SIGN-mediated transmission of human immunodeficiency virus type 1. J. Virol. 2007, 81:2497-2507.
108. Wang S.F., Huang J.C., Lee Y.M., et al. DC-SIGN mediates avian H5N1 influenza virus infection in cis and in trans. Biochem. Biophys. Res. Commun. 2008, 373:561-566.
109. Wichukchinda N., Kitamura Y., Rojanawiwat A., et al. The polymorphisms in DC-SIGNR affect susceptibility to HIV type 1 infection. AIDS Res. Hum. Retroviruses 2007, 23:686-692.
110. Wu L., KewalRamani V.N. Dendritic-cell interactions with HIV: infection and viral dissemination. Nat. Rev. Immunol. 2006, 6:859-868.
111. Wu L., Bashirova A.A., Martin T.D., et al. Rhesus macaque dendritic cells efficiently transmit primate lentiviruses independently of DC-SIGN. Proc. Natl. Acad. Sci. USA 2002, 99:1568-1573.
112. Wu L., Martin T.D., Vazeux R., Unutmaz D., KewalRamani V.N. Functional evaluation of DC-SIGN monoclonal antibodies reveals DC-SIGN interactions with ICAM-3 do not promote human immunodeficiency virus type 1 transmission. J. Virol. 2002, 76:5905-5914.
113. Wu L., Martin T.D., Carrington M., KewalRamani V.N. Raji B cells, misidentified as THP-1 cells, stimulate DC-SIGN-mediated HIV transmission. Virology 2004, 318:17-23.
114. Wu L., Martin T.D., Han Y.C., Breun S.K., KewalRamani V.N. Trans-dominant cellular inhibition of DC-SIGN-mediated HIV-1 transmission. Retrovirology 2004, 1:14.
115. Yang Z.Y., Huang Y., Ganesh L., et al. pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN. J. Virol. 2004, 78:5642-5650.
116. Zhang J., Zhang X., Fu J., et al. Protective role of DC-SIGN (CD209) neck-region alleles with <5 repeat units in HIV-1 transmission. J. Infect. Dis. 2008, 198:68-71.
117. Zhang Z., Schuler T., Zupancic M., et al. Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells. Science 1999, 286:1353-1357.